Landmark Decision Paves the Way for Ozempic Lawsuit Amid Allegations of Concealed Risks
In a significant development, a Louisiana federal judge delivered a blow to Novo Nordisk, refusing to dismiss a pivotal lawsuit concerning the potential side effects of its widely-used drug, Ozempic. The ruling, handed down by U.S. District Judge James Cain Jr, acknowledges the merit in plaintiff Jaclyn Bjorklund’s claims that the pharmaceutical giant failed to …
Landmark Decision Paves the Way for Ozempic Lawsuit Amid Allegations of Concealed Risks Read More »



